Metagenomi Therapeutics (MGX) Earnings Date & Reports

Metagenomi Therapeutics Inc is an vivo genome editing company capitalizing on its proprietary technologies to create curative genetic medicines for patients... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

MGX is expected to report earnings to rise 27.87% to -77 cents per share on August 19

Metagenomi Therapeutics MGX Stock Earnings Reports

Q2'26

Est.

$-0.78

Q1'26

Beat

by $0.17

Q4'25

Beat

by $0.22

Q3'25

Beat

by $0.25

Q2'25

Beat

by $0.18

The last earnings report on May 11 showed earnings per share of -61 cents, beating the estimate of -77 cents. With 54.59K shares outstanding, the current market capitalization sits at 44.80M.

View a ticker or compare two or three

Compare

MGX

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for MGX